These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31271619)

  • 1. Origanum vulgare L. essential oil inhibits the growth of carbapenem-resistant gram-negative bacteria.
    Vasconcelos NG; Croda J; Silva KE; Motta MLL; Maciel WG; Limiere LC; Simionatto S
    Rev Soc Bras Med Trop; 2019 Jun; 52():e20180502. PubMed ID: 31271619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Origanum vulgare essential oil: antibacterial activities and synergistic effect with polymyxin B against multidrug-resistant Acinetobacter baumannii.
    Amaral SC; Pruski BB; de Freitas SB; Allend SO; Ferreira MRA; Moreira C; Pereira DIB; Junior ASV; Hartwig DD
    Mol Biol Rep; 2020 Dec; 47(12):9615-9625. PubMed ID: 33190200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effects of Cinnamomum cassia L. essential oil in combination with polymyxin B against carbapenemase-producing Klebsiella pneumoniae and Serratia marcescens.
    Vasconcelos NG; Queiroz JHFS; Silva KED; Vasconcelos PCP; Croda J; Simionatto S
    PLoS One; 2020; 15(7):e0236505. PubMed ID: 32701970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of tigecycline and comparators (2014-2016) among key WHO 'priority pathogens' and longitudinal assessment (2004-2016) of antimicrobial resistance: a report from the T.E.S.T. study.
    Seifert H; Blondeau J; Dowzicky MJ
    Int J Antimicrob Agents; 2018 Oct; 52(4):474-484. PubMed ID: 30012439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals.
    Falagas ME; Skalidis T; Vardakas KZ; Legakis NJ;
    J Antimicrob Chemother; 2017 Jun; 72(6):1704-1708. PubMed ID: 28369471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of the colistin-rifampicin combination against colistin-resistant, carbapenemase-producing Gram-negative bacteria.
    Nastro M; Rodríguez CH; Monge R; Zintgraff J; Neira L; Rebollo M; Vay C; Famiglietti A
    J Chemother; 2014 Aug; 26(4):211-6. PubMed ID: 24070502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of synergy between sulbactam, meropenem and colistin in carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii isolates and correlation with the molecular mechanism of resistance.
    Laishram S; Anandan S; Devi BY; Elakkiya M; Priyanka B; Bhuvaneshwari T; Peter JV; Subramani K; Balaji V
    J Chemother; 2016 Aug; 28(4):297-303. PubMed ID: 27461479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbapenem and multidrug resistance in Gram-negative bacteria in a single centre in Italy: considerations on in vitro assay of active drugs.
    Mezzatesta ML; Caio C; Gona F; Cormaci R; Salerno I; Zingali T; Denaro C; Gennaro M; Quattrone C; Stefani S
    Int J Antimicrob Agents; 2014 Aug; 44(2):112-6. PubMed ID: 25059444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Warning: spread of NDM-1 in two border towns of Iran.
    Armin S; Fallah F; Azimi L; Samadi Kafil H; Ghazvini K; Hasanzadeh S; Karimi A
    Cell Mol Biol (Noisy-le-grand); 2018 Jul; 64(10):125-129. PubMed ID: 30084804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syzygium aromaticum (clove) and Thymus zygis (thyme) essential oils increase susceptibility to colistin in the nosocomial pathogens Acinetobacter baumannii and Klebsiella pneumoniae.
    Vázquez-Ucha JC; Martínez-Guitián M; Lasarte-Monterrubio C; Conde-Pérez K; Arca-Suárez J; Álvarez-Fraga L; Pérez A; Crecente-Campo J; Alonso MJ; Bou G; Poza M; Beceiro A
    Biomed Pharmacother; 2020 Oct; 130():110606. PubMed ID: 32795924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-oxidant, antibacterial, anti-biofilm, and anti-quorum sensing activities of four essential oils against multidrug-resistant bacterial clinical isolates.
    Alibi S; Ben Selma W; Ramos-Vivas J; Smach MA; Touati R; Boukadida J; Navas J; Ben Mansour H
    Curr Res Transl Med; 2020 Apr; 68(2):59-66. PubMed ID: 32192922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial and anti-PmrA activity of plant essential oils against fluoroquinolone-resistant Streptococcus pneumoniae clinical isolates.
    Ghafari O; Sharifi A; Ahmadi A; Nayeri Fasaei B
    Lett Appl Microbiol; 2018 Dec; 67(6):564-569. PubMed ID: 30007082
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Soudeiha MAH; Dahdouh EA; Azar E; Sarkis DK; Daoud Z
    Front Cell Infect Microbiol; 2017; 7():209. PubMed ID: 28596943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study).
    Kazmierczak KM; Tsuji M; Wise MG; Hackel M; Yamano Y; Echols R; Sahm DF
    Int J Antimicrob Agents; 2019 Feb; 53(2):177-184. PubMed ID: 30395986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of sensitivity to a commercial
    Benameur Q; Gervasi T; Pellizzeri V; Pľuchtová M; Gruľová D; Cicero N; Meriem-Hind B
    Nat Prod Res; 2022 Jun; 36(11):2830-2835. PubMed ID: 34121535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial resistance patterns of Gram-negative bacteria isolated from bloodstream infections in an Iranian referral paediatric hospital: A 5.5-year study.
    Mahmoudi S; Mahzari M; Banar M; Pourakbari B; Haghi Ashtiani MT; Mohammadi M; Keshavarz Valian S; Mamishi S
    J Glob Antimicrob Resist; 2017 Dec; 11():17-22. PubMed ID: 28729206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimum inhibitory concentrations of herbal essential oils and monolaurin for gram-positive and gram-negative bacteria.
    Preuss HG; Echard B; Enig M; Brook I; Elliott TB
    Mol Cell Biochem; 2005 Apr; 272(1-2):29-34. PubMed ID: 16010969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of various essential oils and individual components against extended-spectrum beta-lactamase (ESBL) produced by Klebsiella pneumoniae and their chemical compositions.
    Orhan IE; Ozcelik B; Kan Y; Kartal M
    J Food Sci; 2011 Oct; 76(8):M538-46. PubMed ID: 22417594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piscidin is highly active against carbapenem-resistant Acinetobacter baumannii and NDM-1-producing Klebsiella pneumonia in a systemic Septicaemia infection mouse model.
    Pan CY; Chen JC; Chen TL; Wu JL; Hui CF; Chen JY
    Mar Drugs; 2015 Apr; 13(4):2287-305. PubMed ID: 25874924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro activity of tigecycline against multiple resistant Acinetobacter baumannii and carbapenem resistant Klebsiella pneumoniae isolates].
    Arikan Akan O; Uysal S
    Mikrobiyol Bul; 2008 Apr; 42(2):209-15. PubMed ID: 18697418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.